Greater Cannabis Company (GCAN) Change in Accured Expenses (2016 - 2026)
Greater Cannabis Company's (GCAN) quarterly Change in Accured Expenses came in at $30000.0 in Q1 2026, little changed year-on-year from $30000.0 in Q1 2025, and up 200.0% quarter-over-quarter from $10000.0 in Q4 2025.
Greater Cannabis Company (GCAN) Change in Accured Expenses (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $30000.0 for Q1 2026.
- On a quarterly basis, Change in Accured Expenses changed 0.0% year-over-year to $30000.0 in Q1 2026; TTM through Mar 2026 was $90000.0, a 91.06% increase from a year earlier, with the FY2025 full-year figure at $90000.0, up 295.34% from the prior year.
- Change in Accured Expenses improved to $30000.0 in Q1 2026 per GCAN's latest filing, from $10000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $56400.0 in Q2 2023 and bottomed at -$56962.0 in Q4 2023.
- The 5-year median for Change in Accured Expenses is $10000.0 (2023), against an average of $10599.6.
- Biggest YoY gain for Change in Accured Expenses was 1445.9% in 2023; the steepest drop was 1209.72% in 2023.
- Year by year, Change in Accured Expenses stood at $5133.0 in 2022, then sank by 1209.72% to -$56962.0 in 2023, then jumped by 122.41% to $12765.0 in 2024, then slipped by 21.66% to $10000.0 in 2025, then soared by 200.0% to $30000.0 in 2026.
- Per Business Quant, the three latest GCAN Change in Accured Expenses figures stand at $30000.0 (Q1 2026), $10000.0 (Q4 2025), and $30000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Mar 31, 2025 | 30,000.00 |
| Dec 31, 2024 | 12,765.00 |
| Dec 31, 2024 | 12,765.00 |
| Sep 30, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | -15,660.00 |
| Jun 30, 2024 | -15,660.00 |
| Mar 31, 2024 | 5,660.00 |
| Mar 31, 2024 | 5,660.00 |
| Dec 31, 2023 | -56,962.00 |
| Dec 31, 2023 | -56,962.00 |